380 related articles for article (PubMed ID: 9195222)
1. The clinical spectrum of type IV collagen mutations.
Lemmink HH; Schröder CH; Monnens LA; Smeets HJ
Hum Mutat; 1997; 9(6):477-99. PubMed ID: 9195222
[TBL] [Abstract][Full Text] [Related]
2. Alport syndrome. Molecular genetic aspects.
Hertz JM
Dan Med Bull; 2009 Aug; 56(3):105-52. PubMed ID: 19728970
[TBL] [Abstract][Full Text] [Related]
3. Clinical and molecular diagnosis of Alport syndrome.
Kashtan CE
Proc Assoc Am Physicians; 1995 Oct; 107(3):306-13. PubMed ID: 8608415
[TBL] [Abstract][Full Text] [Related]
4. [Collagen IV (alpha3-alpha4) nephropathy].
Torra R; Tazón B; Ars E; Ballarín J
Nefrologia; 2005; 25 Suppl 2():29-32. PubMed ID: 16050399
[TBL] [Abstract][Full Text] [Related]
5. Autosomal dominant Alport syndrome: molecular analysis of the COL4A4 gene and clinical outcome.
Marcocci E; Uliana V; Bruttini M; Artuso R; Silengo MC; Zerial M; Bergesio F; Amoroso A; Savoldi S; Pennesi M; Giachino D; Rombolà G; Fogazzi GB; Rosatelli C; Martinhago CD; Carmellini M; Mancini R; Di Costanzo G; Longo I; Renieri A; Mari F
Nephrol Dial Transplant; 2009 May; 24(5):1464-71. PubMed ID: 19129241
[TBL] [Abstract][Full Text] [Related]
6. Benign familial hematuria due to mutation of the type IV collagen alpha4 gene.
Lemmink HH; Nillesen WN; Mochizuki T; Schröder CH; Brunner HG; van Oost BA; Monnens LA; Smeets HJ
J Clin Invest; 1996 Sep; 98(5):1114-8. PubMed ID: 8787673
[TBL] [Abstract][Full Text] [Related]
7. [Clinical and genetic features of the Alport 'syndromes'].
Pescucci C; Longo I; Mari F; Scala E; Bruttini M; Caselli R; Renieri A
G Ital Nefrol; 2005; 22(5):466-76. PubMed ID: 16267804
[TBL] [Abstract][Full Text] [Related]
8. [From Alport syndrome to benign familial hematuria: clinical and genetic aspect].
Maziers N; Dahan K; Pirson Y
Nephrol Ther; 2005 May; 1(2):90-100. PubMed ID: 16895672
[TBL] [Abstract][Full Text] [Related]
9. Collagen type IV nephropathy: genetic heterogeneity examinations in affected Hungarian families.
Endreffy E; Ondrik Z; Iványi B; Maróti Z; Bereczki C; Haszon I; Györke Z; Worum E; Németh K; Rikker C; Ökrös Z; Túri S
Mol Cell Probes; 2011 Feb; 25(1):28-34. PubMed ID: 20951199
[TBL] [Abstract][Full Text] [Related]
10. [Alport syndrome or progressive hereditary nephritis with hearing loss].
Gubler MC; Heidet L; Antignac C
Nephrol Ther; 2007 Jun; 3(3):113-20. PubMed ID: 17540313
[TBL] [Abstract][Full Text] [Related]
11. Autosomal recessive Alport syndrome: an in-depth clinical and molecular analysis of five families.
Longo I; Scala E; Mari F; Caselli R; Pescucci C; Mencarelli MA; Speciale C; Giani M; Bresin E; Caringella DA; Borochowitz ZU; Siriwardena K; Winship I; Renieri A; Meloni I
Nephrol Dial Transplant; 2006 Mar; 21(3):665-71. PubMed ID: 16338941
[TBL] [Abstract][Full Text] [Related]
12. Alport syndrome and diffuse leiomyomatosis. Clinical aspects, pathology, molecular biology and extracellular matrix studies. A synthesis.
Garcia-Torres R; Cruz D; Orozco L; Heidet L; Gubler MC
Nephrologie; 2000; 21(1):9-12. PubMed ID: 10730274
[TBL] [Abstract][Full Text] [Related]
13. Novel COL4A5, COL4A4, and COL4A3 mutations in Alport syndrome.
Nagel M; Nagorka S; Gross O
Hum Mutat; 2005 Jul; 26(1):60. PubMed ID: 15954103
[TBL] [Abstract][Full Text] [Related]
14. Alport syndrome and thin basement membrane nephropathy.
Thorner PS
Nephron Clin Pract; 2007; 106(2):c82-8. PubMed ID: 17570934
[TBL] [Abstract][Full Text] [Related]
15. Three novel COL4A4 mutations resulting in stop codons and their clinical effects in autosomal recessive Alport syndrome.
Dagher H; Yan Wang Y; Fassett R; Savige J
Hum Mutat; 2002 Oct; 20(4):321-2. PubMed ID: 12325029
[TBL] [Abstract][Full Text] [Related]
16. Structure of the human type IV collagen COL4A6 gene, which is mutated in Alport syndrome-associated leiomyomatosis.
Zhang X; Zhou J; Reeders ST; Tryggvason K
Genomics; 1996 May; 33(3):473-9. PubMed ID: 8661006
[TBL] [Abstract][Full Text] [Related]
17. Identification of mutations in the alpha 3(IV) and alpha 4(IV) collagen genes in autosomal recessive Alport syndrome.
Mochizuki T; Lemmink HH; Mariyama M; Antignac C; Gubler MC; Pirson Y; Verellen-Dumoulin C; Chan B; Schröder CH; Smeets HJ
Nat Genet; 1994 Sep; 8(1):77-81. PubMed ID: 7987396
[TBL] [Abstract][Full Text] [Related]
18. COL4A3/COL4A4 mutations: from familial hematuria to autosomal-dominant or recessive Alport syndrome.
Longo I; Porcedda P; Mari F; Giachino D; Meloni I; Deplano C; Brusco A; Bosio M; Massella L; Lavoratti G; Roccatello D; Frascá G; Mazzucco G; Muda AO; Conti M; Fasciolo F; Arrondel C; Heidet L; Renieri A; De Marchi M
Kidney Int; 2002 Jun; 61(6):1947-56. PubMed ID: 12028435
[TBL] [Abstract][Full Text] [Related]
19. COL4A4 mutation in thin basement membrane disease previously described in Alport syndrome.
Buzza M; Wang YY; Dagher H; Babon JJ; Cotton RG; Powell H; Dowling J; Savige J
Kidney Int; 2001 Aug; 60(2):480-3. PubMed ID: 11473630
[TBL] [Abstract][Full Text] [Related]
20. Type-IV collagen related diseases.
Pescucci C; Longo I; Bruttini M; Mari F; Renieri A
J Nephrol; 2003; 16(2):314-6. PubMed ID: 12768082
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
